Document Detail


A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings With Regard to Healing Time, Cosmesis, Infection Rate, and Patient's Perceived Pain: A Pilot Study.
MedLine Citation:
PMID:  21844815     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This study was undertaken to compare pain, healing time, infection rate, and cosmetic outcome between Aquacel Ag (Convatec) and Glucan II (Brennan Medical) as donor site dressings. The authors performed a prospective, randomized, patient-controlled study. Eligible patients had two donor sites harvested. One site was dressed with Aquacel Ag and the other site with Glucan II. Patients were followed at set time points for 6 months to determine the rate of epithelialization, patient's perceived pain, infection rate, and the cosmetic outcome. A total of 20 patients were enrolled in the study. All patient data were collected through reepithelialization. The average time to wound healing for Aquacel Ag was 12.5 ± 2.07 days compared with Glucan II 12.7 ± 1.99 days. Perceived pain scores for each donor site were recorded. On postoperative day 5, patients reported significantly less pain with the Aquacel Ag site (Aquacel Ag 1.75 vs Glucan II 2.5, P = .02). Three donor sites showed clinical signs of infection (two Glucan II and one Aquacel Ag) prompting culture and dressing removal. There was no statistically significant difference in cosmetic outcomes of the donor sites at any time point. When comparing Aquacel Ag and Glucan II, our study has determined that there is no significant difference with regard to healing time, infection rates, and cosmetic outcomes. Both dressings are comparable with regard to ease of application and postoperative care.
Authors:
Suzanne Bailey; Melissa Carmean; Marianne Cinat; Kimberly Burton; Christopher Lane; Darren Malinoski
Related Documents :
21369925 - Inadequacy of present polyspecific anti snakevenom - a study from central kerala.
20664905 - Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-13
Journal Detail:
Title:  Journal of burn care & research : official publication of the American Burn Association     Volume:  -     ISSN:  1559-0488     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101262774     Medline TA:  J Burn Care Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
From the •••.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Review of Ectodermal Dysplasia: Case Report on Treatment Planning and Surgical Management of Oligodo...
Next Document:  Metastatic tumor of the heart: description of a case.